Abstract:Elevated levels of MMP‐1, MMP‐2, MMP‐3, OPN, and TSLP were detected at sites affected by periodontitis and peri‐implantitis compared to sites with healthy teeth and implants. The cytokine OPN may serve as a biomarker for periodontitis, whereas the proteolytic enzyme MMP‐2 and the cytokine TSLP might be potential biomarkers for both periodontitis and peri‐implantitis. Aim Periodontitis and peri‐implantitis are chronic inflammatory diseases characterized by the destruction of supporting tissues. Despite some similarities, it is essential to understand the differences in how these diseases elicit unique host responses within the oral tissues, including the production of selected matrix metalloproteinases (MMPs) and inflammatory mediators involved in tissue remodelling. The aim of this study was to evaluate the levels of proteolytic enzymes MMP‐1, MMP‐2, MMP‐3, as well as the inflammatory mediators osteopontin (OPN), pentraxin‐3 (PTX3), and thymic stromal lymphopoietin (TSLP) in crevicular fluid samples collected from healthy, periodontitis‐affected, and peri‐implantitis sites. Methods Gingival crevicular fluid (GCF) and peri‐implant crevicular fluid (PICF) samples were collected from healthy and diseased teeth and implant sites of 163 patients. The MMP‐1, MMP‐2, MMP‐3, OPN, PTX3, and TSLP levels were determined using commercially available immunoassays. A linear mixed model procedure was adopted for multilevel analyses, using biomarker levels as the outcome variable to compare two types of sites. The diagnostic accuracy of the biomarkers was evaluated by Youden's index to estimate the sensitivity, specificity and the area under curve (AUC). Results The levels of MMP‐1, MMP‐2, MMP‐3, OPN, and TSLP were higher at sites with periodontitis and peri‐implantitis compared to the levels at sites with healthy teeth and healthy implants. No significant differences were observed in the levels of the measured markers between the sites diagnosed with periodontitis and those diagnosed with peri‐implantitis. The highest diagnostic potential at implant sites was found for MMP‐2 (AUC = 0.74) and TSLP (AUC = 0.72). The highest AUC (0.82) at tooth sites was found for OPN. Conclusions The findings indicate that the proteolytic enzyme MMP‐2 and the cytokine TSLP might be potential biomarkers for both periodontitis and peri‐implantitis, whereas the proinflammatory cytokine OPN may serve as a biomarker for periodontitis. Further studies are required to confirm the utility of these biomarkers and explore their potential clinical applications.

In Vivo Regulation of Active Matrix Metalloproteinase-8 (aMMP-8) in Periodontitis: From Transcriptomics to Real-Time Online Diagnostics and Treatment Monitoring

Expressions of MMP-8 and TIMP-1 in Gingival Tissue of Patients with Aggressive Periodontitis

Expressions of MMP-1,MMP-8 and MMP-13 in gingival tissue of patients with aggressive periodontitis

aMMP-8 POCT vs. Other Potential Biomarkers in Chair-Side Diagnostics and Treatment Monitoring of Severe Periodontitis

Active Matrix Metalloproteinase-8 (aMMP-8) Versus Total MMP-8 in Periodontal and Peri-Implant Disease Point-of-Care Diagnostics

aMMP-8 point-of-care - diagnostic methods and treatment modalities in periodontitis and peri-implantitis

Importance of Metalloproteinase 8 (MMP-8) in the Diagnosis of Periodontitis

Prediabetes Associates with Matrix Metalloproteinase-8 Activation and Contributes to the Rapid Destruction of Periodontal Tissues

MMP-7 and TIMP-1, new targets in predicting poor wound healing in apical periodontitis

Periodontal Treatment Reduces Matrix Metalloproteinase Levels in Localized Aggressive Periodontitis

Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic

Extracellular Release of a Disintegrin and Metalloproteinase Correlates With Periodontal Disease Severity

Gingival crevicular fluid matrix metalloproteinase-25 and -26 levels in periodontal disease

Matrix metalloproteinase 9 level changes in gingival crevicular fluid samples of teeth with acute and chronic apical periodontitis

Diagnostic accuracy of a point‐of‐care aMMP‐8 test in the discrimination of periodontal health and disease

Levels of matrix metalloproteinase‐1 (MMP‐1), MMP‐2, MMP‐3, osteopontin, pentraxin‐3, and thymic stromal lymphopoietin in crevicular fluid samples from peri‐implantitis, periodontitis, and healthy sites

Salivary matrix metalloproteinase (MMP)-8 as a biomarker for periodontitis: A PRISMA-compliant systematic review and meta-analysis.

aMMP-8 Oral Fluid PoC Test in Relation to Oral and Systemic Diseases

Expression of IL-1β, IL-6, TNF-α, and a-MMP-8 in sites with healthy conditions and with periodontal and peri-implant diseases: A case-control study

Expression of selected inflammatory proteins and metalloproteinases in periodontitis

Validation of a noninvasive aMMP-8 point-of-care diagnostic methodology in COVID-19 patients with periodontal disease